All In MedTech

Device Trial Radar · NCT01394978

NeoMend ProGEL™ Pleural Air Leak Sealant Post-Approval Study

AirTight: A Prospective Controlled Post-Approval Study of NeoMend ProGEL™ Pleural Air Leak Sealant in the Treatment of Visible Pleural Air Leaks After Standard Pleural Closure

Last checked: Nov 19, 2026Latest source record: Jul 15, 2021 (this record)Source: ClinicalTrials.govMethods & limitations

CompletedResults posted on the registry

Status

Completed

Enrollment

444

Actual

Start

Jun 2011

Primary completion

Feb 2016

Study completion Feb 2016

Sponsor

Lead sponsor
C. R. BardPublic (BDX)
Sponsor type
Industry
First posted
Jul 15, 2011

More device trials from this sponsor

Design

Study type
Interventional
Phase
Not applicable (typical for device studies)
Allocation
Non randomized
Model
Parallel
Masking
None
Primary purpose
Treatment
Who can join
All sexes, from 18 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

The purpose of this post approval study is to further characterize the safety profile of the ProGEL™ Pleural Air Leak Sealant in commercial use, with specific reference to long-term safety over 90 days of follow-up.

Conditions

  • Lung Cancer
  • Lung Tumor

Interventions

  • ControlOther

    Standard surgical techniques including staples and sutures.

  • ProGEL Pleural Air Leak Sealant with standard surgical closureDevice

    ProGEL is a single-use medical device that is formed as a result of mixing two components: (1) a solution of human serum albumin (HSA) and (2) a synthetic cross-linking component of polyethylene glycol (PEG). Standard closure means, for example, suturing or stapling of visible air leaks incurred during resection of lung parenchyma.

  • ProGEL Pleural Air Leak Sealant without standard surgical closureDevice

    ProGEL is a single-use medical device that is formed as a result of mixing two components: (1) a solution of human serum albumin (HSA) and (2) a synthetic cross-linking component of polyethylene glycol (PEG). Standard closure means, for example, suturing or stapling of visible air leaks incurred during resection of lung parenchyma.

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Safety EndpointsTime frame: 90 days

Locations

18 sites in 1 country. Site status is shown where the registry gives one.

  • St. Vincent Birmingham & St. Vincent East

    Birmingham, Alabama

  • University of Alabama in Birmingham

    Birmingham, Alabama

  • Jacksonville Center for Research

    Jacksonville, Florida

15 more study sites with a free account

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.